Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...
An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...
A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...
As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...
The claim that Moderna’s CEO confessed to creating a COVID vaccine before the pandemic is false. His remarks at Davos 2023 ...
To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...
Moderna stock tumbled after the Senate Finance Committee voted to send RFK Jr.'s nomination for the HHS secretary to the full ...
Buying stocks at significantly reduced valuations can lead to some incredible returns later on. But that doesn't mean that ...
Investing.com -- Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% ...
Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform ...